H. Levillain

International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

D. Sze, S. Kappadath, D. Madoff, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer

P. Flamen, B. Vanderlinden, N. Reynaert, 2020, EJNMMI Physics.

Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study

P. Flamen, L. Ameye, B. Vanderlinden, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Selective internal radiation therapy (SIRT) before partial hepatectomy or radiofrequency destruction for treatment of hepatocellular carcinoma in cirrhotic patients: a feasibility and safety pilot study.

P. Flamen, V. Donckier, B. Vanderlinden, 2018, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Radiomics software comparison using digital phantom and patient data: IBSI-compliance does not guarantee concordance of feature values

J. Dhont, N. Reynaert, M. Bali, 2022, Biomedical physics & engineering express.

Pre-trial quality assurance of diffusion-weighted MRI for radiomic analysis and the role of harmonisation.

J. Dhont, N. Reynaert, G. Bregni, 2022, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy

R. Velthoven, T. Gil, S. Albisinni, 2019, World Journal of Urology.

Prognostic value of a three-scale grading system based on combining molecular imaging with 68Ga-DOTATATE and 18F-FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasias

P. Flamen, A. Hendlisz, G. Machiels, 2020, Oncotarget.

90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer

P. Flamen, B. Vanderlinden, N. Reynaert, 2018, EJNMMI Research.

The metabolic clinical risk score as a new prognostic model for surgical decision‐making in patients with colorectal liver metastases

N. Trotta, S. Goldman, G. Van Simaeys, 2019, Journal of surgical oncology.

Clinical impact of 99mTc-MAA SPECT/CT-based personalized predictive dosimetry in selective internal radiotherapy: a real-life single-center experience in unresectable HCC patients

N. Trotta, G. Verset, J. Van Laethem, 2023, European Journal of Hybrid Imaging.

Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study

P. Flamen, L. Ameye, B. Vanderlinden, 2023, The Journal of Nuclear Medicine.

177Lu-DOTATATE PRRT Safety and Organ-at-Risk Dosimetry in Patients With Gastroenteropancreatic Neuroendocrine Tumors: Data From the Prospective Phase 2 LUMEN Study.

P. Flamen, L. Ameye, Rachele Danieli, 2024, Clinical nuclear medicine.

Quantitative 177Lu SPECT/CT imaging for personalized dosimetry using a ring-shaped CZT-based camera

P. Flamen, B. Vanderlinden, Rachele Danieli, 2023, EJNMMI Physics.